-
1
-
-
84872109456
-
The global prevalence of dementia: a systematic review and metaanalysis
-
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP, The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 2013;9:63–75.e2. doi: 10.1016/j.jalz.2012.11.007 23305823
-
(2013)
Alzheimers Dement
, vol.9
, pp. 63-75
-
-
Prince, M.1
Bryce, R.2
Albanese, E.3
Wimo, A.4
Ribeiro, W.5
Ferri, C.P.6
-
2
-
-
84897954407
-
Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers
-
Reitz C, Mayeux R, Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochem Pharmacol. 2014;88:640–651. doi: 10.1016/j.bcp.2013.12.024 24398425
-
(2014)
Biochem Pharmacol
, vol.88
, pp. 640-651
-
-
Reitz, C.1
Mayeux, R.2
-
3
-
-
84874455392
-
Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship
-
Vagelatos NT, Eslick GD, Type 2 diabetes as a risk factor for Alzheimer’s disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev. 2013;35:152–160. doi: 10.1093/epirev/mxs012 23314404
-
(2013)
Epidemiol Rev
, vol.35
, pp. 152-160
-
-
Vagelatos, N.T.1
Eslick, G.D.2
-
4
-
-
84881221053
-
Glucose levels and risk of dementia
-
Crane PK, Walker R, Hubbard RA, Li G, Nathan DM, Zheng H, et al. Glucose levels and risk of dementia. N Engl J Med. 2013;369:540–548. doi: 10.1056/NEJMoa1215740 23924004
-
(2013)
N Engl J Med
, vol.369
, pp. 540-548
-
-
Crane, P.K.1
Walker, R.2
Hubbard, R.A.3
Li, G.4
Nathan, D.M.5
Zheng, H.6
-
5
-
-
80051669619
-
The projected effect of risk factor reduction on Alzheimer’s disease prevalence
-
Barnes DE, Yaffe K, The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol. 2011;10:819–828. doi: 10.1016/S1474-4422(11)70072-2 21775213
-
(2011)
Lancet Neurol
, vol.10
, pp. 819-828
-
-
Barnes, D.E.1
Yaffe, K.2
-
6
-
-
84879779694
-
Development of a new method for assessing global risk of Alzheimer’s disease for use in population health approaches to prevention
-
Anstey KJ, Cherbuin N, Herath PM, Development of a new method for assessing global risk of Alzheimer’s disease for use in population health approaches to prevention. Prev Sci. 2013;14:411–421. doi: 10.1007/s11121-012-0313-2 23319292
-
(2013)
Prev Sci
, vol.14
, pp. 411-421
-
-
Anstey, K.J.1
Cherbuin, N.2
Herath, P.M.3
-
7
-
-
12744273863
-
Midlife cardiovascular risk factors and risk of dementia in late life
-
Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K, Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277–281. 15668425
-
(2005)
Neurology
, vol.64
, pp. 277-281
-
-
Whitmer, R.A.1
Sidney, S.2
Selby, J.3
Johnston, S.C.4
Yaffe, K.5
-
8
-
-
51249112496
-
Smoking, dementia and cognitive decline in the elderly, a systematic review
-
Peters R, Poulter R, Warner J, Beckett N, Burch L, Bulpitt C, Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatr. 2008;8:36. doi: 10.1186/1471-2318-8-36 19105840
-
(2008)
BMC Geriatr
, vol.8
, pp. 36
-
-
Peters, R.1
Poulter, R.2
Warner, J.3
Beckett, N.4
Burch, L.5
Bulpitt, C.6
-
9
-
-
84904264999
-
Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data
-
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C, Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13:788–794. doi: 10.1016/S1474-4422(14)70136-X 25030513
-
(2014)
Lancet Neurol
, vol.13
, pp. 788-794
-
-
Norton, S.1
Matthews, F.E.2
Barnes, D.E.3
Yaffe, K.4
Brayne, C.5
-
10
-
-
84872042939
-
Use of Mendelian randomisation to assess potential benefit of clinical intervention
-
Burgess S, Butterworth A, Malarstig A, Thompson SG, Use of Mendelian randomisation to assess potential benefit of clinical intervention. BMJ. 2012;345:e7325. doi: 10.1136/bmj.e7325 23131671
-
(2012)
BMJ
, vol.345
, pp. 7325
-
-
Burgess, S.1
Butterworth, A.2
Malarstig, A.3
Thompson, S.G.4
-
11
-
-
0037322022
-
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?
-
Davey Smith G, Ebrahim S, ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1–22. 12689998
-
(2003)
Int J Epidemiol
, vol.32
, pp. 1-22
-
-
Davey Smith, G.1
Ebrahim, S.2
-
12
-
-
84888317489
-
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease
-
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45:1452–1458. doi: 10.1038/ng.2802 24162737
-
(2013)
Nat Genet
, vol.45
, pp. 1452-1458
-
-
Lambert, J.C.1
Ibrahim-Verbaas, C.A.2
Harold, D.3
Naj, A.C.4
Sims, R.5
Bellenguez, C.6
-
13
-
-
84868337361
-
Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
-
Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–990. doi: 10.1038/ng.2383 22885922
-
(2012)
Nat Genet
, vol.44
, pp. 981-990
-
-
Morris, A.P.1
Voight, B.F.2
Teslovich, T.M.3
Ferreira, T.4
Segre, A.V.5
Steinthorsdottir, V.6
-
14
-
-
84865693929
-
Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways
-
Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44:991–1005. doi: 10.1038/ng.2385 22885924
-
(2012)
Nat Genet
, vol.44
, pp. 991-1005
-
-
Scott, R.A.1
Lagou, V.2
Welch, R.P.3
Wheeler, E.4
Montasser, M.E.5
Luan, J.6
-
15
-
-
84911949202
-
Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independently of obesity
-
Scott RA, Fall T, Pasko D, Barker A, Sharp SJ, Arriola L, et al. Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independently of obesity. Diabetes. 2014;63:4378–4387. doi: 10.2337/db14-0319 24947364
-
(2014)
Diabetes
, vol.63
, pp. 4378-4387
-
-
Scott, R.A.1
Fall, T.2
Pasko, D.3
Barker, A.4
Sharp, S.J.5
Arriola, L.6
-
16
-
-
78049337953
-
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index
-
Speliotes EK, Willer CJ, Berndt SI, Monda KL, Thorleifsson G, Jackson AU, et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet. 2010;42:937–948. doi: 10.1038/ng.686 20935630
-
(2010)
Nat Genet
, vol.42
, pp. 937-948
-
-
Speliotes, E.K.1
Willer, C.J.2
Berndt, S.I.3
Monda, K.L.4
Thorleifsson, G.5
Jackson, A.U.6
-
17
-
-
80053907554
-
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk
-
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, International Consortium for Blood Pressure Genome-Wide Association Studies, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–109. doi: 10.1038/nature10405 21909115
-
(2011)
Nature
, vol.478
, pp. 103-109
-
-
Ehret, G.B.1
Munroe, P.B.2
Rice, K.M.3
Bochud, M.4
Johnson, A.D.5
-
18
-
-
80053383403
-
Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure
-
Wain LV, Verwoert GC, O’Reilly PF, Shi G, Johnson T, Johnson AD, et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43:1005–1011. doi: 10.1038/ng.922 21909110
-
(2011)
Nat Genet
, vol.43
, pp. 1005-1011
-
-
Wain, L.V.1
Verwoert, G.C.2
O’Reilly, P.F.3
Shi, G.4
Johnson, T.5
Johnson, A.D.6
-
19
-
-
84887099827
-
Discovery and refinement of loci associated with lipid levels
-
Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Global Lipids Genetics Consortium, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–1283. doi: 10.1038/ng.2797 24097068
-
(2013)
Nat Genet
, vol.45
, pp. 1274-1283
-
-
Willer, C.J.1
Schmidt, E.M.2
Sengupta, S.3
Peloso, G.M.4
Gustafsson, S.5
-
20
-
-
77951711343
-
Genome-wide meta-analyses identify multiple loci associated with smoking behavior
-
Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010;42:441–447. doi: 10.1038/ng.571 20418890
-
(2010)
Nat Genet
, vol.42
, pp. 441-447
-
-
-
21
-
-
84879271608
-
GWAS of 126,559 individuals identifies genetic variants associated with educational attainment
-
Rietveld CA, Medland SE, Derringer J, Yang J, Esko T, Martin NW, et al. GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science. 2013;340:1467–1471. doi: 10.1126/science.1235488 23722424
-
(2013)
Science
, vol.340
, pp. 1467-1471
-
-
Rietveld, C.A.1
Medland, S.E.2
Derringer, J.3
Yang, J.4
Esko, T.5
Martin, N.W.6
-
22
-
-
84885840876
-
Mendelian randomization analysis with multiple genetic variants using summarized data
-
Burgess S, Butterworth A, Thompson SG, Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–665. doi: 10.1002/gepi.21758 24114802
-
(2013)
Genet Epidemiol
, vol.37
, pp. 658-665
-
-
Burgess, S.1
Butterworth, A.2
Thompson, S.G.3
-
23
-
-
77955501246
-
Association between birth weight and visceral fat in adults
-
Rolfe Ede L, Loos RJ, Druet C, Stolk RP, Ekelund U, Griffin SJ, et al. Association between birth weight and visceral fat in adults. Am J Clin Nutr. 2010;92:347–352. doi: 10.3945/ajcn.2010.29247 20519560
-
(2010)
Am J Clin Nutr
, vol.92
, pp. 347-352
-
-
Rolfe Ede, L.1
Loos, R.J.2
Druet, C.3
Stolk, R.P.4
Ekelund, U.5
Griffin, S.J.6
-
24
-
-
79955464911
-
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease
-
Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet. 2011;43:436–441. doi: 10.1038/ng.801 21460841
-
(2011)
Nat Genet
, vol.43
, pp. 436-441
-
-
Naj, A.C.1
Jun, G.2
Beecham, G.W.3
Wang, L.S.4
Vardarajan, B.N.5
Buros, J.6
-
25
-
-
70349558522
-
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease
-
Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet. 2009;41:1088–1093. doi: 10.1038/ng.440 19734902
-
(2009)
Nat Genet
, vol.41
, pp. 1088-1093
-
-
Harold, D.1
Abraham, R.2
Hollingworth, P.3
Sims, R.4
Gerrish, A.5
Hamshere, M.L.6
-
26
-
-
80054698404
-
Design and cohort description of the InterAct project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC study
-
Langenberg C, Sharp S, Forouhi NG, Franks PW, Schulze MB, InterAct Consortium, et al. Design and cohort description of the InterAct project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC study. Diabetologia. 2011;54:2272–2282. doi: 10.1007/s00125-011-2182-9 21717116
-
(2011)
Diabetologia
, vol.54
, pp. 2272-2282
-
-
Langenberg, C.1
Sharp, S.2
Forouhi, N.G.3
Franks, P.W.4
Schulze, M.B.5
-
27
-
-
11144357626
-
Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism
-
Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, et al. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat. 2004;23:358–367. 15024730
-
(2004)
Hum Mutat
, vol.23
, pp. 358-367
-
-
Katzov, H.1
Chalmers, K.2
Palmgren, J.3
Andreasen, N.4
Johansson, B.5
Cairns, N.J.6
-
28
-
-
80051547314
-
The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis
-
Power MC, Weuve J, Gagne JJ, McQueen MB, Viswanathan A, Blacker D, The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology. 2011;22:646–659. doi: 10.1097/EDE.0b013e31822708b5 21705906
-
(2011)
Epidemiology
, vol.22
, pp. 646-659
-
-
Power, M.C.1
Weuve, J.2
Gagne, J.J.3
McQueen, M.B.4
Viswanathan, A.5
Blacker, D.6
-
29
-
-
0034594441
-
Midlife blood pressure and dementia:the Honolulu-Asia aging study
-
Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia:the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49–55. 10794848
-
(2000)
Neurobiol Aging
, vol.21
, pp. 49-55
-
-
Launer, L.J.1
Ross, G.W.2
Petrovitch, H.3
Masaki, K.4
Foley, D.5
White, L.R.6
-
30
-
-
0035897938
-
Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study
-
Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer’s disease in later life: longitudinal, population based study. BMJ. 2001;322:1447–1451. 11408299
-
(2001)
BMJ
, vol.322
, pp. 1447-1451
-
-
Kivipelto, M.1
Helkala, E.L.2
Laakso, M.P.3
Hanninen, T.4
Hallikainen, M.5
Alhainen, K.6
-
31
-
-
70049117978
-
Low diastolic pressure and risk of dementia in very old people: a longitudinal study
-
Qiu C, Winblad B, Fratiglioni L, Low diastolic pressure and risk of dementia in very old people: a longitudinal study. Dement Geriatr Cogn Disord. 2009;28:213–219. doi: 10.1159/000236913 19752556
-
(2009)
Dement Geriatr Cogn Disord
, vol.28
, pp. 213-219
-
-
Qiu, C.1
Winblad, B.2
Fratiglioni, L.3
-
32
-
-
84881290888
-
Dementia and lower blood pressure in Latin America, India, and China: a 10/66 cross-cohort study
-
Albanese E, Lombardo FL, Prince MJ, Stewart R, Dementia and lower blood pressure in Latin America, India, and China: a 10/66 cross-cohort study. Neurology. 2013;81:228–235. doi: 10.1212/WNL.0b013e31829bfe66 23771488
-
(2013)
Neurology
, vol.81
, pp. 228-235
-
-
Albanese, E.1
Lombardo, F.L.2
Prince, M.J.3
Stewart, R.4
-
33
-
-
0029962107
-
Low blood pressure and dementia in elderly people: the Kungsholmen project
-
Guo Z, Viitanen M, Fratiglioni L, Winblad B, Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ. 1996;312:805–808. 8608286
-
(1996)
BMJ
, vol.312
, pp. 805-808
-
-
Guo, Z.1
Viitanen, M.2
Fratiglioni, L.3
Winblad, B.4
-
34
-
-
84871396053
-
Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia
-
de la Torre JC, Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia. Cardiovasc Psychiatry Neurol. 2012;2012:367516. doi: 10.1155/2012/367516 23243502
-
(2012)
Cardiovasc Psychiatry Neurol
, vol.2012
, pp. 367516
-
-
de la Torre, J.C.1
-
35
-
-
0037079309
-
Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
-
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913. 12493255
-
(2002)
Lancet
, vol.360
, pp. 1903-1913
-
-
Lewington, S.1
Clarke, R.2
Qizilbash, N.3
Peto, R.4
Collins, R.5
-
36
-
-
0032564132
-
Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial
-
Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347–1351. 9802273
-
(1998)
Lancet
, vol.352
, pp. 1347-1351
-
-
Forette, F.1
Seux, M.L.2
Staessen, J.A.3
Thijs, L.4
Birkenhager, W.H.5
Babarskiene, M.R.6
-
37
-
-
84884628143
-
Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study
-
Yasar S, Xia J, Yao W, Furberg CD, Xue QL, Mercado CI, et al. Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study. Neurology. 2013;81:896–903. doi: 10.1212/WNL.0b013e3182a35228 23911756
-
(2013)
Neurology
, vol.81
, pp. 896-903
-
-
Yasar, S.1
Xia, J.2
Yao, W.3
Furberg, C.D.4
Xue, Q.L.5
Mercado, C.I.6
-
38
-
-
0037078312
-
The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (Syst-Eur) study
-
Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al. The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162:2046–2052. 12374512
-
(2002)
Arch Intern Med
, vol.162
, pp. 2046-2052
-
-
Forette, F.1
Seux, M.L.2
Staessen, J.A.3
Thijs, L.4
Babarskiene, M.R.5
Babeanu, S.6
-
39
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
-
Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002;360:1623–1630. 12457784
-
(2002)
Lancet
, vol.360
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
Bollen, E.L.4
Buckley, B.M.5
Cobbe, S.M.6
-
40
-
-
0025740733
-
Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group
-
Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, et al. Alcohol and tobacco consumption as risk factors for Alzheimer’s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol. 1991;20(Suppl 2):S48–S57. 1833354
-
(1991)
Int J Epidemiol
, vol.20
, pp. 48-57
-
-
Graves, A.B.1
van Duijn, C.M.2
Chandra, V.3
Fratiglioni, L.4
Heyman, A.5
Jorm, A.F.6
-
41
-
-
0029956783
-
Nicotine inhibits amyloid formation by the beta-peptide
-
Salomon AR, Marcinowski KJ, Friedland RP, Zagorski MG, Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry. 1996;35:13568–13578. 8885836
-
(1996)
Biochemistry
, vol.35
, pp. 13568-13578
-
-
Salomon, A.R.1
Marcinowski, K.J.2
Friedland, R.P.3
Zagorski, M.G.4
-
42
-
-
0027337861
-
Smoking and Alzheimer’s disease: protective effect or differential survival bias?
-
Riggs JE, Smoking and Alzheimer’s disease: protective effect or differential survival bias? Lancet. 1993;342:793–794. 8103882
-
(1993)
Lancet
, vol.342
, pp. 793-794
-
-
Riggs, J.E.1
-
43
-
-
82955220531
-
Chronic stress and Alzheimer’s disease-like pathogenesis in a rat model: prevention by nicotine
-
Alkadhi KA, Chronic stress and Alzheimer’s disease-like pathogenesis in a rat model: prevention by nicotine. Curr Neuropharmacol. 2011;9:587–597. doi: 10.2174/157015911798376307 22654719
-
(2011)
Curr Neuropharmacol
, vol.9
, pp. 587-597
-
-
Alkadhi, K.A.1
-
44
-
-
81455135676
-
Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index
-
Freathy RM, Kazeem GR, Morris RW, Johnson PC, Paternoster L, Ebrahim S, et al. Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index. Int J Epidemiol. 2011;40:1617–1628. doi: 10.1093/ije/dyr077 21593077
-
(2011)
Int J Epidemiol
, vol.40
, pp. 1617-1628
-
-
Freathy, R.M.1
Kazeem, G.R.2
Morris, R.W.3
Johnson, P.C.4
Paternoster, L.5
Ebrahim, S.6
-
45
-
-
84871055775
-
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
-
Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–2260. doi: 10.1016/S0140-6736(12)61766-8 23245609
-
(2012)
Lancet
, vol.380
, pp. 2224-2260
-
-
Lim, S.S.1
Vos, T.2
Flaxman, A.D.3
Danaei, G.4
Shibuya, K.5
Adair-Rohani, H.6
-
46
-
-
84907956274
-
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis
-
Proitsi P, Lupton MK, Velayudhan L, Newhouse S, Fogh I, Tsolaki M, et al. Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis. PLoS Med. 2014;11:e1001713. doi: 10.1371/journal.pmed.1001713 25226301
-
(2014)
PLoS Med
, vol.11
, pp. 1001713
-
-
Proitsi, P.1
Lupton, M.K.2
Velayudhan, L.3
Newhouse, S.4
Fogh, I.5
Tsolaki, M.6
-
47
-
-
0027194791
-
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families
-
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 1993;261:921–923. 8346443
-
(1993)
Science
, vol.261
, pp. 921-923
-
-
Corder, E.H.1
Saunders, A.M.2
Strittmatter, W.J.3
Schmechel, D.E.4
Gaskell, P.C.5
Small, G.W.6
-
48
-
-
84876295965
-
Identification of a functional apolipoprotein E promoter polymorphism regulating plasma apolipoprotein E concentration
-
Mannila MN, Mahdessian H, Franco-Cereceda A, Eggertsen G, de Faire U, Syvanen AC, et al. Identification of a functional apolipoprotein E promoter polymorphism regulating plasma apolipoprotein E concentration. Arterioscler Thromb Vasc Biol. 2013;33:1063–1069. doi: 10.1161/ATVBAHA.112.300353 23430611
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 1063-1069
-
-
Mannila, M.N.1
Mahdessian, H.2
Franco-Cereceda, A.3
Eggertsen, G.4
de Faire, U.5
Syvanen, A.C.6
|